Liana O Ventura1, Camila V Ventura2, Natália de C Dias3, Isabelle G Vilar3, Adriana L Gois2, Tiago E Arantes3, Luciene C Fernandes4, Michael F Chiang5, Marilyn T Miller6, Linda Lawrence7. 1. Department of Ophthalmology, Altino Ventura Foundation, Recife, Pernambuco, Brazil; Department of Ophthalmology, HOPE Eye Hospital, Recife, Pernambuco, Brazil. Electronic address: lianaventuramd@gmail.com. 2. Department of Ophthalmology, Altino Ventura Foundation, Recife, Pernambuco, Brazil; Department of Ophthalmology, HOPE Eye Hospital, Recife, Pernambuco, Brazil. 3. Department of Ophthalmology, Altino Ventura Foundation, Recife, Pernambuco, Brazil. 4. Department of Low Vision, Federal University of Minas Gerais, Belo Horizonte, Minas Gerias, Brazil. 5. Department of Ophthalmology, Casey Eye Institute at Oregon Health & Science University, Portland, Oregon. 6. Department of Ophthalmology, University of Illinois, Chicago. 7. Department of Ophthalmology, University of Kansas School of Medicine, Kansas City, Kansas.
Abstract
PURPOSE: To assess visual impairment in a large sample of infants with congenital Zika syndrome (CZS) and to compare with a control group using the same assessment protocol. METHODS: The study group was composed of infants with confirmed diagnosis of CZS. Controls were healthy infants matched for age, sex, and socioeconomic status. All infants underwent comprehensive ophthalmologic evaluation including visual acuity, visual function assessment, and visual developmental milestones. RESULTS: The CZS group included 119 infants; the control group, 85 infants. At examination, the mean age of the CZS group was 8.5 ± 1.2 months (range, 6-13 months); of the controls, 8.4 ± 1.8 months (range, 5-12 months; P = 0.598). Binocular Teller Acuity Card (TAC) testing was abnormal in 107 CZS infants and in 4 controls (89.9% versus 5% [P < 0.001]). In the study group, abnormal monocular TAC results were more frequent in eyes with funduscopic alterations (P = 0.008); however, 104 of 123 structurally normal eyes (84.6%) also presented abnormal TAC results. Binocular contrast sensitivity was reduced in 87 of 107 CZS infants and in 8 of 80 controls (81.3% versus 10% [P < 0.001]). The visual development milestones were less achieved by infants with CZS compared to controls (P < 0.001). CONCLUSIONS: Infants with CZS present with severe visual impairment. A protocol for assessment of the ocular findings, visual acuity, and visual developmental milestones tested against age-matched controls is suggested.
PURPOSE: To assess visual impairment in a large sample of infants with congenital Zika syndrome (CZS) and to compare with a control group using the same assessment protocol. METHODS: The study group was composed of infants with confirmed diagnosis of CZS. Controls were healthy infants matched for age, sex, and socioeconomic status. All infants underwent comprehensive ophthalmologic evaluation including visual acuity, visual function assessment, and visual developmental milestones. RESULTS: The CZS group included 119 infants; the control group, 85 infants. At examination, the mean age of the CZS group was 8.5 ± 1.2 months (range, 6-13 months); of the controls, 8.4 ± 1.8 months (range, 5-12 months; P = 0.598). Binocular Teller Acuity Card (TAC) testing was abnormal in 107 CZSinfants and in 4 controls (89.9% versus 5% [P < 0.001]). In the study group, abnormal monocular TAC results were more frequent in eyes with funduscopic alterations (P = 0.008); however, 104 of 123 structurally normal eyes (84.6%) also presented abnormal TAC results. Binocular contrast sensitivity was reduced in 87 of 107 CZSinfants and in 8 of 80 controls (81.3% versus 10% [P < 0.001]). The visual development milestones were less achieved by infants with CZS compared to controls (P < 0.001). CONCLUSIONS:Infants with CZS present with severe visual impairment. A protocol for assessment of the ocular findings, visual acuity, and visual developmental milestones tested against age-matched controls is suggested.
Authors: Andrea A Zin; Irena Tsui; Julia D Rossetto; Stephanie L Gaw; Luiza M Neves; Olivia A Zin; Lorena Haefeli; Joel Carlos Barros Silveira Filho; Kristina Adachi; Marcos Vinicius da Silva Pone; Sheila Moura Pone; Natalia Molleri; Jose Paulo Pereira; Rubens Belfort; Vaithilingaraja Arumugaswami; Zilton Vasconcelos; Patricia Brasil; Karin Nielsen-Saines; Maria Elisabeth Lopes Moreira Journal: J AAPOS Date: 2018-10-22 Impact factor: 1.220
Authors: Kevin K Noguchi; Brant S Swiney; Sasha L Williams; Jacob N Huffman; Katherine Lucas; Sophie H Wang; Kayla M Kapral; Amber Li; Krikor T Dikranian Journal: J Neurosci Date: 2019-12-13 Impact factor: 6.167
Authors: S Grace Prakalapakorn; Lucas Bonafede; Linda Lawrence; Daniel Lattin; Nicola Kim; Richard D House; Braeanna Hillman; Leah de Wilde; Cosme Harrison; Nicole Fehrenbach; Shana Godfred-Cato; Megan R Reynolds; Esther M Ellis Journal: Trop Med Infect Dis Date: 2021-04-29
Authors: Kristina Adachi; Tahmineh Romero; Karin Nielsen-Saines; Sheila Pone; Mitsue Aibe; Elisa Barroso de Aguiar; Myung Sim; Patricia Brasil; Andrea Zin; Irena Tsui; Stephanie L Gaw; Umme-Aiman Halai; Zilton Vasconcelos; Jose Paulo Pereira; Tania Saad Salles; Claudia Neves Barbosa; Elyzabeth Portari; James D Cherry; Marcos Pone; Maria Elisabeth Moreira Journal: Clin Infect Dis Date: 2020-06-10 Impact factor: 20.999
Authors: Oliver J Brady; Aaron Osgood-Zimmerman; Nicholas J Kassebaum; Sarah E Ray; Valdelaine E M de Araújo; Aglaêr A da Nóbrega; Livia C V Frutuoso; Roberto C R Lecca; Antony Stevens; Bruno Zoca de Oliveira; José M de Lima; Isaac I Bogoch; Philippe Mayaud; Thomas Jaenisch; Ali H Mokdad; Christopher J L Murray; Simon I Hay; Robert C Reiner; Fatima Marinho Journal: PLoS Med Date: 2019-03-05 Impact factor: 11.069
Authors: Maria-Lucia C Lage; Alessandra L de Carvalho; Paloma A Ventura; Tania B Taguchi; Adriana S Fernandes; Suely F Pinho; Onildo T Santos-Junior; Clara L Ramos; Cristiana M Nascimento-Carvalho Journal: Int J Environ Res Public Health Date: 2019-01-23 Impact factor: 3.390
Authors: Rosemary J Steinbach; Nicole N Haese; Jessica L Smith; Lois M A Colgin; Rhonda P MacAllister; Justin M Greene; Christopher J Parkins; J Beth Kempton; Edward Porsov; Xiaojie Wang; Lauren M Renner; Trevor J McGill; Brandy L Dozier; Craig N Kreklywich; Takeshi F Andoh; Marjorie R Grafe; Heidi L Pecoraro; Travis Hodge; Robert M Friedman; Lisa A Houser; Terry K Morgan; Peter Stenzel; Jonathan R Lindner; Robert L Schelonka; Jonah B Sacha; Victoria H J Roberts; Martha Neuringer; John V Brigande; Christopher D Kroenke; Antonio E Frias; Anne D Lewis; Meredith A Kelleher; Alec J Hirsch; Daniel Neal Streblow Journal: PLoS One Date: 2020-01-14 Impact factor: 3.240